The effect of gut microbiota on the formation of calcium oxalate kidney stones

doi:10.3877/cma.j.issn.1674-3253.2024.05.015

Abstract

Abstract:

Renal calculi is one of the most common urinary diseases, and its incidence rate is increasing due to genetic and environmental factors. Most kidney stones are calcium oxalate stones, which are also one of the types of kidney stones with a higher risk of recurrence. The frequent recurrence of kidney stones leads to serious complications and high treatment costs. There is currently no effective method to prevent kidney stones. As research deepens, more and more evidence suggests that gut microbiota may play an important role in the pathogenesis and prevention of kidney stones. This article aims to provide a review on the relationship between gut microbiota and the formation, prevention, and treatment of calcium oxalate kidney stones.

Key words: Renal calculi, Calcium oxalate, Gut microbiota, Probiotics

Daocheng Fang, Chunhua Tang, Yuanyuan Hu. The effect of gut microbiota on the formation of calcium oxalate kidney stones[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(05): 509-513.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2024.05.015

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2024/V18/I05/509

References 59

[1]	Mayans L. Nephrolithiasis[J]. Prim Care, 2019, 46(2): 203-212.
[2]	Kittanamongkolchai W, Vaughan LE, Enders FT, et al. The changing incidence and presentation of urinary stones over 3 decades[J]. Mayo Clin Proc, 2018, 93(3): 291-299.
[3]	D'Costa MR, Pais VM, Rule AD. Leave no stone unturned: defining recurrence in kidney stone formers[J]. Curr Opin Nephrol Hypertens, 2019, 28(2): 148-153.
[4]	王友铭, 许长宝, 王晓甫, 等. 河南省泌尿系结石住院患者流行病学特点及分析[J]. 临床泌尿外科杂志, 2021, 36(6): 458-463.
[5]	Ye Z, Zeng G, Yang H, et al. The status and characteristics of urinary stone composition in China[J]. BJU Int, 2020, 125(6): 801-809.
[6]	Wang Z, Zhang Y, Zhang J, et al. Recent advances on the mechanisms of kidney stone formation (Review)[J]. Int J Mol Med, 2021, 48(2): 149.
[7]	Whittamore JM, Hatch M. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man[J]. Urolithiasis, 2017, 45(1): 89-108.
[8]	Ticinesi A, Nouvenne A, Meschi T. Gut microbiome and kidney stone disease: not just an Oxalobacter story[J]. Kidney Int, 2019, 96(1): 25-27.
[9]	Evenepoel P, Poesen R, Meijers B. The gut-kidney axis[J]. Pediatr Nephrol, 2017, 32(11): 2005-2014.
[10]	熊磊, 吕建林. 肠道微生物群落与草酸钙结石的关系研究进展[J]. 现代泌尿外科杂志, 2020, 25(8): 756-759.
[11]	Miller AW, Orr T, Dearing D, et al. Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet[J]. ISME J, 2019, 13(6): 1379-1390.
[12]	Lieske JC. Probiotics for prevention of urinary stones[J]. Ann Transl Med, 2017, 5(2): 29.
[13]	Allison MJ, Dawson KA, Mayberry WR, et al. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract[J]. Arch Microbiol, 1985, 141(1): 1-7.
[14]	Pebenito AM, Liu M, Nazzal L, et al. Development of a humanized murine model for the study of oxalobacter formigenes intestinal colonization[J]. J Infect Dis, 2019, 220(11): 1848-1858.
[15]	Arvans D, Jung YC, Antonopoulos D, et al. Oxalobacter formigenes-Derived bioactive factors stimulate oxalate transport by intestinal epithelial cells[J]. J Am Soc Nephrol, 2017, 28(3): 876-887.
[16]	Stern JM, Urban-Maldonado M, Usyk M, et al. Fecal transplant modifies urine chemistry risk factors for urinary stone disease[J]. Physiol Rep, 2019, 7(4): e14012.
[17]	Daniel SL, Moradi L, Paiste H, et al. Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist[J]. Appl Environ Microbiol, 2021, 87(18): e0054421.
[18]	张帝, 汤晓静, 高远, 等. 产甲酸草酸杆菌预防草酸钙肾结石的作用[J]. 中华肾脏病杂志, 2019, 35(4): 288-294.
[19]	Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones[J]. J Am Soc Nephrol, 2008, 19(6): 1197-1203.
[20]	Tavasoli S, Alebouyeh M, Naji M, et al. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study[J]. BJU Int, 2020, 125(1): 133-143.
[21]	Miller AW, Oakeson KF, Dale C, et al. Microbial community transplant results in increased and long-term oxalate degradation[J]. Microb Ecol, 2016, 72(2): 470-478.
[22]	Kharlamb V, Schelker J, Francois F, et al. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes[J]. J Endourol, 2011, 25(11): 1781-1785.
[23]	PeBenito A, Nazzal L, Wang C, et al. Comparative prevalence of Oxalobacter formigenes in three human populations[J]. Sci Rep, 2019, 9(1): 574.
[24]	Nazzal L, Francois F, Henderson N, et al. Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretion[J]. Sci Rep, 2021, 11(1): 16428.
[25]	Liu M, Koh H, Kurtz ZD, et al. Oxalobacter formigenes-associated host features and microbial community structures examined using the American Gut Project[J]. Microbiome, 2017, 5(1): 108.
[26]	Chen YY, Chen DQ, Chen L, et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease[J]. J Transl Med, 2019, 17(1): 5.
[27]	Pedro RN, Aslam AU, Bello JO, et al. Nutrients, vitamins, probiotics and herbal products: an update of their role in urolithogenesis[J]. Urolithiasis, 2020, 48(4): 285-301.
[28]	Suryavanshi MV, Bhute SS, Gune RP, et al. Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease[J]. Sci Rep, 2018, 8(1): 16598.
[29]	Ellis ME, Mobley JA, Holmes RP, et al. Proteome dynamics of the specialist oxalate degrader Oxalobacter formigenes[J]. J Proteomics Bioinform, 2016, 9(1): 19-24.
[30]	Ellis ML, Dowell AE, Li X, et al. Probiotic properties of Oxalobacter formigenes: an in vitro examination[J]. Arch Microbiol, 2016, 198(10): 1019-1026.
[31]	Milliner D, Hoppe B, Groothoff J. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria[J]. Urolithiasis, 2018, 46(4): 313-323.
[32]	Maresca D, Zotta T, Mauriello G. Adaptation to aerobic environment of lactobacillus johnsonii/gasseri strains[J]. Front Microbiol, 2018, 9: 157.
[33]	Martín R, Langella P. Emerging health concepts in the probiotics field: streamlining the definitions[J]. Front Microbiol, 2019, 10: 1047.
[34]	Le B, Yang SH. Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease[J]. Toxicol Rep, 2018, 5: 314-317.
[35]	Mu Q, Tavella VJ, Luo XM. Role of Lactobacillus reuteri in human health and diseases[J]. Front Microbiol, 2018, 9: 757.
[36]	刘建利, 何旭, 孙钦飞. 降解草酸盐乳酸菌株的筛选及其酸乳发酵特性[J]. 食品工业科技, 2021, 42(12): 111-118.
[37]	Sadaf H, Raza SI, Hassan SW. Role of gut microbiota against calcium oxalate[J]. Microb Pathog, 2017, 109: 287-291.
[38]	国立东, 王丽群, 于纯淼, 等. 乳酸菌降解草酸盐活性及机制研究进展[J]. 食品科学, 2018, 39(3): 324-329.
[39]	Paul E, Albert A, Ponnusamy S, et al. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats[J]. Microbiol Res, 2018, 215: 65-75.
[40]	Giardina S, Scilironi C, Michelotti A, et al. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria[J]. J Food Sci, 2014, 79(3): M384-M390.
[41]	Wei Z, Cui Y, Tian L, et al. Probiotic Lactiplantibacillus plantarum N-1 could prevent ethylene glycol-induced kidney stones by regulating gut microbiota and enhancing intestinal barrier function[J]. FASEB J, 2021, 35(11): e21937.
[42]	Zampini A, Nguyen AH, Rose E, et al. Defining dysbiosis in patients with urolithiasis[J]. Sci Rep, 2019, 9(1): 5425.
[43]	Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration[J]. Kidney Int, 2001, 60(3): 1097-1105.
[44]	Ferraz RR, Marques NC, Froeder L, et al. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients[J]. Urol Res, 2009, 37(2): 95-100.
[45]	Lieske JC, Tremaine WJ, De Simone C, et al. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation[J]. Kidney Int, 2010, 78(11): 1178-1185.
[46]	Siener R, Bade DJ, Hesse A, et al. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria[J]. J Transl Med, 2013, 11: 306.
[47]	Al-Wahsh I, Wu Y, Liebman M. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects[J]. Urol Res, 2012, 40(3): 191-196.
[48]	Hidalgo-Cantabrana C, Delgado S, Ruiz L, et al. Bifidobacteria and their health-promoting effects[J]. Microbiol Spectr, 2017, 5(3).
[49]	Turroni S, Bendazzoli C, Dipalo S C, et al. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes[J]. Appl Environ Microbiol, 2010, 76(16): 5609-5620.
[50]	火玮. 肠道菌群对草酸钙结石形成影响进展[J]. 国际泌尿系统杂志, 2019, 39(5): 924-926.
[51]	Mehra Y, Rajesh NG, Viswanathan P. Analysis and characterization of lactobacillus paragasseri and lacticaseibacillus paracasei: two probiotic bacteria that can degrade intestinal oxalate in hyperoxaluric rats[J]. Probiotics Antimicrob Proteins, 2022, 14(5): 854-872.
[52]	Arafa A, Eshak ES, Iso H. Oxalates, urinary stones and risk of cardiovascular diseases[J]. Med Hypotheses, 2020, 137: 109570.
[53]	Ito H, Miura N, Masai M, et al. Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1[J]. Int J Urol, 1996, 3(1): 31-34.
[54]	Ito H, Kotake T, Masai M. In vitro degradation of oxalic acid by human feces[J]. Int J Urol, 1996, 3(3): 207-211.
[55]	Fiore E, van Tyne D, Gilmore MS. Pathogenicity of enterococci[J]. Microbiol Spectr, 2019, 7(4): 10.
[56]	Ramos S, Silva V, Dapkevicius MLE, et al. Enterococci, from harmless bacteria to a pathogen[J]. Microorganisms, 2020, 8(8): 1118.
[57]	Amimanan P, Tavichakorntrakool R, Fong-Ngern K, et al. Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation[J]. Sci Rep, 2017, 7(1): 2953.
[58]	赖德辉, 李名钊, 盛明, 等. 表达甲酰辅酶A转移酶的大肠杆菌对大鼠尿草酸浓度的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(5): 352-355.
[59]	Chapman CMC, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains?[J]. Eur J Nutr, 2011, 50(1): 1-17.

Please choose a citation manager

Content to export